The role of CD19+CD24highCD38high and CD19+CD24highCD27+ regulatory B cells in patients with type 1 autoimmune pancreatitis

Pancreatology

Volumn 14, Issue 3, 2014, Pages 193-200

  Sumimoto, Kimi ^a   Uchida, Kazushige ^a   Kusuda, Takeo ^a   Mitsuyama, Toshiyuki ^a   Sakaguchi, Yutaku ^a   Fukui, Toshiro ^a   Matsushita, Mitsunobu ^a   Takaoka, Makoto ^a   Nishio, Akiyoshi ^a   Okazaki, Kazuichi ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Interleukin 10 (IL 10); Regulatory B cells (Bregs); Type 1 autoimmune pancreatitis (AIP)

Indexed keywords

INTERLEUKIN 10; BIOLOGICAL MARKER; CD19 ANTIGEN; CD24 ANTIGEN; CD27 ANTIGEN; CD38 ANTIGEN; CD38 PROTEIN, HUMAN; IL10 PROTEIN, HUMAN; MEMBRANE PROTEIN;

ADULT; AGED; ARTICLE; AUTOIMMUNE PANCREATITIS; AUTOIMMUNE PANCREATITIS TYPE 1; B LYMPHOCYTE; CD19+ CD24 CD27+ B LYMPHOCYTE; CD19+ CD24 CD38 B LYMPHOCYTE; CHRONIC PANCREATITIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; AUTOIMMUNE DISEASE; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PANCREATITIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD19; ANTIGENS, CD24; ANTIGENS, CD27; ANTIGENS, CD38; AUTOIMMUNE DISEASES; B-LYMPHOCYTES, REGULATORY; BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-10; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PANCREATITIS;

EID: 84905858883     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1016/j.pan.2014.02.004     Document Type: Article

References (69)

1. Sarles H, Sarles JC, Muratore R, Guien C. Chronic inflammatory sclerosis of the pancreas e an autonomous pancreatic disease? Am J Dig Dis 1961;6:688-98.
2. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995;40:1561-8.
3. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732-8.
4. Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003;38:982-4.
5. Uchida K, Okazaki K, Konishi Y, Ohana M, Takakuwa H, Hajiro K, et al. Clinical analysis of autoimmune-related pancreatitis. Am J Gastroenterol 2000;95:2788-94.
6. Okazaki K, Uchida K, Chiba T. Recent concept of autoimmune-related pancreatitis. J Gastroenterol 2001;36:293-302.
7. Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut 2002;51:1-4.
8. Uchida K, Okazaki K, Asada M, Yazumi S, Ohana M, Chiba T, et al. Case of chronic pancreatitis involving an autoimmune mechanism that extended to retroperitoneal fibrosis. Pancreas 2003;26:92-4.
9. Kim KP, Kim MH, Song MH, Lee SS, Seo DW, Lee SK. Autoimmune chronic pancreatitis. Am J Gastroenterol 2004;99:1605-16.
10. Shimosegawa T, Kanno A. Autoimmune pancreatitis in Japan: overview and perspective. J Gastroenterol 2009;44:503-17.
11. Finkelberg DL, Sahani D, Deshpande V, Brugge WR. Autoimmune pancreatitis. N Engl J Med 2006;355:2670-6.
12. Pickartz T, Mayerle J, Lerch MM. Autoimmune pancreatitis. Nat Clin Pract Gastroenterol Hepatol 2007;4:314-23.
13. Okazaki K, Kawa S, Kamisawa T, Naruse S, Tanaka S, Nishimori I, et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol 2006;41:626-31.
14. Chari ST, Smyrk TC, Levy MJ, Topazian MD, Takahashi N, Zhang L, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 2006;4:1010-6 [quiz 934].
15. Kim KP, Kim MH, Kim JC, Lee SS, Seo DW, Lee SK. Diagnostic criteria for autoimmune chronic pancreatitis revisited. World J Gastroenterol 2006;12:2487-96.
16. Park SW, Chung JB, Otsuki M, Kim MH, Lim JH, Kawa S, et al. Conference report: KoreaeJapan symposium on autoimmune pancreatitis. Gut Liver 2008;2:81-7.
17. Otsuki M, Chung JB, Okazaki K, Kim MH, Kamisawa T, Kawa S, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the JapaneKorea symposium on autoimmune pancreatitis. J Gastroenterol 2008;43:403-8.
18. Chari ST, Takahashi N, Levy MJ, Smyrk TC, Clain JE, Pearson RK, et al. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol 2009;7:1097-103.
19. Kamisawa T, Notohara K, Shimosegawa T. Two clinicopathologic subtypes of autoimmune pancreatitis: LPSP and IDCP. Gastroenterology 2010;139:22-5.
20. Park DH, Kim MH, Chari ST. Recent advances in autoimmune pancreatitis. Gut 2009;58:1680-9.
21. Chari ST, Klöeppel G, Zhang L, Notohara K, Lerch MM, Shimosegawa T, et al. Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas 2010;39:549-54.
22. Klöppel G, Detlefsen S, Chari ST, Longnecker DS, Zamboni G. Autoimmune pancreatitis: the clinicopathological characteristics of the subtype with granulocytic epithelial lesions. J Gastroenterol 2010;45:787-93.
23. Notohara K, Burgart LJ, Yadav D, Chari S, Smyrk TC. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases. Am J Surg Pathol 2003;27:1119-27.
24. Zamboni G, Lüttges J, Capelli P, Frulloni L, Cavallini G, Pederzoli P, et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 2004;445:552-63.
25. Kamisawa T, Kim MH, Liao WC, Liu Q, Balakrishnan V, Okazaki K, et al. Clinical characteristics of 327 Asian patients with autoimmune pancreatitis based on Asian diagnostic criteria. Pancreas 2011;40:200-5.
26. Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011;40:352-8.
27. Shimosegawa T, Working Group Members of the Japan Pancreas Society, Research Committee for Intractable Pancreatic Disease by the Ministry of Labor, Health and Welfare of Japan. The amendment of the clinical diagnostic criteria in Japan (JPS2011) in response to the proposal of the international consensus of diagnostic criteria (ICDC) for autoimmune pancreatitis. Pancreas 2012;41:1341-2.
28. Miyoshi H, Uchida K, Taniguchi T, Yazumi S, Matsushita M, Takaoka M, et al. Circulating naïve and CD4+CD25high regulatory T cells in patients with autoimmune pancreatitis. Pancreas 2008;36:133-40.
29. Kusuda T, Uchida K, Miyoshi H, Koyabu M, Satoi S, Takaoka M, et al. Involvement of inducible costimulator- and interleukin 10-positive regulatory T cells in the development of IgG4-related autoimmune pancreatitis. Pancreas 2011;40:1120-30.
30. Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 2002;16:219-30.
31. Fujita S, Seino K, Sato K, Sato Y, Eizumi K, Yamashita N, et al. Regulatory dendritic cells act as regulators of acute lethal systemic inflammatory response. Blood 2006;107:3656-64.
32. Murai M, Turovskaya O, Kim G, Madan R, Karp CL, Cheroutre H, et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol 2009;10:1178-84.
33. Hoshino S, Kurishima A, Inaba M, Ando Y, Fukui T, Uchida K, et al. Amelioration of 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis in mice by immunoregulatory dendritic cells. J Gastroenterol 2011;46:1368-81.
34. Das A, Ellis G, Pallant C, Lopes AR, Khanna P, Peppa D, et al. IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J Immunol 2012;189:3925-35.
35. Li X, Zhong H, Bao W, Boulad N, Evangelista J, Haider MA, et al. Defective regulatory B-cell compartment in patients with immune thrombocytopenia. Blood 2012;120:3318-25.
36. Saussine A, Tazi A, Feuillet S, Rybojad M, Juillard C, Bergeron A, et al. Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels. PLoS One 2012;7:e43588.
37. Chen T, Song D, Min Z, Wang X, Gu Y, Wei B, et al. Perioperative dynamic alterations in peripheral regulatory T and B cells in patients with hepatocellular carcinoma. J Transl Med 2012;10:14.
38. Blair PA, Noreña LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, et al. CD19 (+) CD24 (hi) CD38 (hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010;32:129-40.
39. Di Lillo DJ, Horikawa M, Tedder TF. B-lymphocyte effector functions in health and disease. Immunol Res 2011;49:281-92.
40. Iwata Y, Matsushita T, Horikawa M, Dilillo DJ, Yanaba K, Venturi GM, et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 2011;117:530-41.
41. Hart PA, Topazian MD, Witzig TE, Clain JE, Gleeson FC, Klebiq RR, et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut 2013;62:1607-15.
42. Shimosegawa T, Kataoka K, Kamisawa T, Miyakawa H, Ohara H, Ito T, et al. The revised Japanese clinical diagnostic criteria for chronic pancreatitis. J Gastroenterol 2010;45:584-91.
43. Okazaki K, Uchida K, Ohana M, Nakase H, Uose S, Inai M, et al. Autoimmunerelated pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response. Gastroenterology 2000;118:573-81.
44. Mizoguchi A, Bhan AK. A case for regulatory B cells. J Immunol 2006;176:705-10.
45. Neta R, Salvin SB. Specific suppression of delayed hypersensitivity: the possible presence of a suppressor B cell in the regulation of delayed hypersensitivity. J Immunol 1974;113:1716-25.
46. Wolf SD, Dittel BN, Hardardottir F, Janeway Jr CA. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med 1996;184:2271-8.
47. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002;3:944-50.
48. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008;28:639-50.
49. Duddy M, Niino M, Adatia F, Hebert S, Freedman M, Atkins H, et al. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol 2007;178:6092-9.
50. Kaminski DA, Letterio JJ, Burrows PD. Differential regulation of mouse B cell development by transforming growth factor beta1. Dev Immunol 2002;9:85-95.
51. Hilbig A, Oettle H. Transforming growth factor beta in pancreatic cancer. Curr Pharm Biotechnol 2011;12:2158-64.
52. Saraiva M, O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010;10:170-81.
53. Moore KW, De Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
54. O'Garra A, Vieira P. T (H) 1 cells control themselves by producing interleukin-10. Nat Rev Immunol 2007;7:425-8.
55. Trinchieri G. Interleukin-10 production by effector T cells: Th1 cells show self control. J Exp Med 2007;204:239-43.
56. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 2006;212:28-50.
57. Maynard CL, Weaver CT. Diversity in the contribution of interleukin-10 to Tcellmediated immune regulation. Immunol Rev 2008;226:219-33.
58. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001;2:816-22.
59. Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol 2012;30:221-41.
60. Yang M, Rui K, Wang S, Lu L. Regulatory B cells in autoimmune diseases. Cell Mol Immunol 2013;10:122-32.
61. Tian J, Zekzer D, Hanssen L, Lu Y, Olcott A, Kaufman DL. Lipopolysaccharideactivated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol 2001;167:1081-9.
62. Schultze JL, Michalak S, Lowne J, Wong A, Gilleece MH, Gribben JG, et al. Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cell signals CD40 ligand, interferon gamma, and IL-10: role of B cells in the maintenance of T cell responses. J Exp Med 1999;189:1-12.
63. Watanabe T, Yamashita K, Sakurai T, Kudo M, Shiokawa M, Uza N, et al. Tolllike receptor activation in basophils contributes to the development of IgG4-related disease. J Gastroenterol 2013;48:247-53.
64. Watanabe T, Yamashita K, Fujikawa S, Sakurai T, Kudo M, Shiokawa M, et al. Involvement of activation of toll-like receptors and nucleotide-binding oligomerization domain-like receptors in enhanced IgG4 responses in autoimmune pancreatitis. Arthritis Rheum 2012;64:914-24.
65. Koyabu M, Uchida K, Sakaguchi Y, Fukata N, Kusuda T, Miyoshi H, et al. Possible involvement of Foxp3 (+) regulatory T cells in the development of immune-mediated pancreatitis in MRL/Mp mice treated with Polyinosinic: Polycytidylic acid. Int J Rheumatol 2013;2013:367325.
66. Sakaguchi Y, Inaba M, Tsuda M, Quan GK, Omae M, Ando Y, et al. The Wistar Bonn Kobori rat, a unique animal model for autoimmune pancreatitis with extrapancreatic exocrinopathy. Clin Exp Immunol 2008;152:1-12.
67. Koyabu M, Uchida K, Miyoshi H, Sakaguchi Y, Fukui T, Ikeda H, et al. Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases. J Gastroenterol 2010;45:732-41.
68. Uchida K, Kusuda T, Koyabu M, Miyoshi H, Fukata M, Sumimoto K, et al. Regulatory T cells in type 1 autoimmune pancreatitis. Int J Rheumatol 2012;2012:795026.
69. Okazaki K, Uchida K, Koyabu M, Miyoshi H, Takaoka M. Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease. J Gastroenterol 2011;46:277-88.